Loading data
EUDANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.82 m USD | 4.01 m USD | 3.71 m USD | 3.76 m USD | 4.56 m USD |
| Cost of revenue | 3.83 m USD | 3.25 m USD | 2.86 m USD | 2.89 m USD | 3.31 m USD |
| Gross profit | 2.99 m USD | 762.16 k USD | 842.08 k USD | 870 k USD | 1.25 m USD |
| Research and development expense | 249 USD | — | — | 17.21 k USD | 129.27 k USD |
| Operating profit | -2.48 m USD | -17.34 m USD | -3.96 m USD | -12.22 m USD | -559.99 k USD |
| Profit before tax | -2.73 m USD | -17.64 m USD | -8.43 m USD | -25.03 m USD | 1.67 m USD |
| Income tax expense | 41.94 k USD | -4.38 k USD | — | -20.79 k USD | 46.49 k USD |
| Net income (reported basis) | -2.77 m USD | -15.36 m USD | -10.04 m USD | -24.88 m USD | 864.83 k USD |
| Net income attributable to common shareholders | — | -17.6 m USD | -8.44 m USD | -24.94 m USD | 1.59 m USD |
| Basic earnings per share | -1.48 USD/share | -9.46 USD/share | -8.77 USD/share | -2.07 USD/share | 0.09 USD/share |
| Diluted earnings per share | -1.48 USD/share | -9.46 USD/share | -8.77 USD/share | -2.07 USD/share | 0.09 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.